By continuing to use this site you consent to the use of cookies on your device. Find out more about our cookie policy and the types of cookies we use by clicking here.

Franklin Biotechnology Discv A(acc)USD

Performance History30/06/2017
Growth of 1,000 (EUR)
Franklin Biotechnology Discv A(acc)USD
Fund57.253.416.9-15.45.6
+/-Cat6.04.9-2.51.7-3.9
+/-Idx-3.34.5-3.0-5.9-0.8
 
Key Stats
NAV
21/07/2017
 USD 32.11
Day Change 0.30%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
30/06/2017
 USD 2408.64
Share Class Size (Mil)
30/06/2017
 USD 1989.92
Max Initial Charge 5.75%
Ongoing Charge
27/01/2017
  1.83%
Investment Objective: Franklin Biotechnology Discv A(acc)USD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns21/07/2017
YTD7.37
3 Years Annualised15.03
5 Years Annualised18.72
10 Years Annualised15.55
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Steven Kornfeld
15/09/2015
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv A(acc)USD30/06/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks96.460.0096.46
Bonds0.000.000.00
Cash2.310.002.31
Other1.230.001.23
Top 5 Regions%
United States97.12
Middle East0.83
United Kingdom0.69
Eurozone0.58
Canada0.48
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.69
Alexion Pharmaceuticals IncHealthcareHealthcare7.67
Incyte CorpHealthcareHealthcare5.88
Regeneron Pharmaceuticals IncHealthcareHealthcare5.56
Biogen IncHealthcareHealthcare4.75
Franklin Biotechnology Discv A(acc)USD